Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2721 Results
Researchers Uncover New Gene for Heart Failure in Caucasians

Researchers Uncover New Gene for Heart Failure in Caucasians

Nearly five million Americans live with heart failure, with as many as 700,000 new cases diagnosed each year. In addition to lifestyle factors, scientists have shown that heart failure has a strong heritable component, but identifying the responsible genes has been a major challenge.

Jessica Mikulski

Certain Genetic Profiles Increase Risk of Coronary Artery Disease, While Others Increase Risk of Heart Attack

Certain Genetic Profiles Increase Risk of Coronary Artery Disease, While Others Increase Risk of Heart Attack

(PHILADELPHIA) – Coronary artery disease (CAD) is the single largest cause of death in adults in the United States. Until recently, the genetic basis of CAD has been largely unknown, with just a few proven genes (typically genes for cholesterol disorders) accounting for very little of the disease in the population.

Jessica Mikulski

Penn Study Shows New Measure Trumps HDL Levels in Protecting Against Heart Disease

Penn Study Shows New Measure Trumps HDL Levels in Protecting Against Heart Disease

(PHILADELPHIA) – The discovery that high levels of high-density lipoprotein (HDL) cholesterol (the “good cholesterol”) is associated with reduced risk of cardiovascular disease has fostered intensive research to modify HDL levels for therapeutic gain.

Jessica Mikulski

Malfunctioning Gene Associated With Lou Gehrig’s Disease Leads to Nerve-Cell Death in Mice

Malfunctioning Gene Associated With Lou Gehrig’s Disease Leads to Nerve-Cell Death in Mice

PHILADELPHIA – Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration (FTLD) are characterized by protein clumps in brain and spinal-cord cells that include an RNA-binding protein called TDP-43. This protein is the major building block of the lesions formed by these clumps.

Karen Kreeger

Penn Medicine Selected as Field Trial Site for DSM-5

Penn Medicine Selected as Field Trial Site for DSM-5

PHILADELPHIA – Penn Medicine has been selected as one of seven adult field trial sites to test proposed diagnostic criteria for the American Psychiatric Association’s (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM).

Kim Menard

Structure of Key Molecule in Immune System Provides Clues for Designing Drugs, According to Penn Study

Structure of Key Molecule in Immune System Provides Clues for Designing Drugs, According to Penn Study

PHILADELPHIA - A team from the University of Pennsylvania School of Medicine and Utrecht University has deciphered a key step in an evolutionarily old branch of the immune response. This system, called complement, comprises a network of proteins that “complement” the work of antibodies in destroying foreign invaders.

Karen Kreeger

Penn Researchers Identify Potential Target for Breast Cancer Therapy

Penn Researchers Identify Potential Target for Breast Cancer Therapy

PHILADELPHIA – Overexpression or hyperactivation of ErbB cell-surface receptors drives the growth of many breast cancers. Drugs, like Herceptin, that block the receptors’ signals halt tumor progression in some patients. However, not all patients’ tumors respond, with some becoming resistant over time.

Karen Kreeger

Penn Medicine Establishes Hand Transplant Program

Penn Medicine Establishes Hand Transplant Program

PHILADELPHIA - The Penn Transplant Institute, the Department of Orthopaedic Surgery and the Division of Plastic Surgery at the Hospital of the University of Pennsylvania (HUP) have collaborated to form the Penn Hand Transplant Program.

Olivia Fermano

Weightlifting Slashes Lymphedema Risk After Breast Cancer Treatment

Weightlifting Slashes Lymphedema Risk After Breast Cancer Treatment

(SAN ANTONIO) -- Weightlifting may play a key role in a program to prevent the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine.

Holly Auer